Related Experiment Videos

Serine-protease inhibitors modulate nitric oxide-synthase activity of alveolar macrophages

P G Jorens1, F J Van Overeld, H Bult

  • 1Department of Respiratory Medicine, University of Antwerp (UIA), Belgium.

Agents and Actions
|July 1, 1992
PubMed

Insights

Serine protease inhibitors block L-arginine metabolism in rat alveolar macrophages, suggesting a role in lung injury. This finding offers new ways to study inflammatory pathways in lung phagocytic cells.

Area of Science:

  • Immunology
  • Cell Biology
  • Pulmonary Medicine

Background:

  • Macrophages, immune cells found in tissues, produce L-arginine-derived nitrogen oxides when stimulated.
  • This pathway is implicated in lung injury and has been identified in rat alveolar macrophages.

Purpose of the Study:

  • To investigate the role of serine proteases in the L-arginine metabolic pathway in rat alveolar macrophages.
  • To explore the potential of protease inhibitors in modulating this inflammatory pathway.

Main Methods:

  • Rat alveolar macrophages were stimulated in vitro with lipopolysaccharide and interferon-gamma.
  • The effect of irreversible serine protease inhibitors (N-tosyl-L-phenylalanine chloromethyl-ketone and N-tosyl-L-lysine chloromethyl-ketone) and reversible inhibitors on nitrite production was measured.

Main Results:

  • Nitrite production was inhibited by both irreversible and reversible serine protease inhibitors in a concentration-dependent manner.
  • Irreversible inhibitors showed greater efficacy in blocking nitrite production compared to reversible ones.

Conclusions:

  • Serine proteases play a role in the L-arginine metabolic pathway in rat alveolar macrophages.
  • Protease inhibitors can modulate this pathway, offering potential therapeutic targets for lung inflammatory conditions.

Related Concept Videos